Truist Raises Eli Lilly Price Target to $1,612, Maintains Buy
Truist raised its price target on Eli Lilly to $1,612 from $1,376 and maintained a Buy rating.
Truist raised its price target on Eli Lilly to $1,612 from $1,376 and maintained a Buy rating.